EPISODE · Dec 10, 2024 · 27 MIN
The Cancer Journey
from The Clinical Excellence Podcast · host Adam Cifu, MD
In this episode, Dr. Adam Cifu sits down with Dr. Chadi Nabhan—a hematologist, oncologist, author, and healthcare leader—to discuss his inspiring career transitions and his latest book, The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention. They explore the phases of a cancer diagnosis, the emotional toll on patients and caregivers, and the critical role of communication and second opinions. Dr. Nabhan also shares insights from his work at a company advancing AI technology to accelerate clinical trials. He is also the author of Toxic Exposure: The True Story Behind the Monsanto Trials and the Search for Justice.To learn more about Dr. Nabhan's The Cancer Journey and read an article about the book, visit ASCO Connection: https://connection.asco.org/magazine/features/cancer-journey-dr-chadi-nabhan-uses-storytelling-plain-language-simplify-complex.
What this episode covers
In this episode, Dr. Adam Cifu sits down with Dr. Chadi Nabhan—a hematologist, oncologist, author, and healthcare leader—to discuss his inspiring career transitions and his latest book, The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention. They explore the phases of a cancer diagnosis, the emotional toll on patients and caregivers, and the critical role of communication and second opinions. Dr. Nabhan also shares insights from his work at a company advancing AI technology to accelerate clinical trials. He is also the author of Toxic Exposure: The True Story Behind the Monsanto Trials and the Search for Justice.To learn more about Dr. Nabhan's The Cancer Journey and read an article about the book, visit ASCO Connection: https://connection.asco.org/magazine/features/cancer-journey-dr-chadi-nabhan-uses-storytelling-plain-language-simplify-complex.
NOW PLAYING
The Cancer Journey
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m